Groundbreaking RIO Trial Results: Long-Acting Antibodies Achieve Sustained HIV Remission
The groundbreaking RIO trial has revealed unprecedented results, demonstrating that long-acting antibodies can sustain H...
Read More →The groundbreaking RIO trial has revealed unprecedented results, demonstrating that long-acting antibodies can sustain H...
Read More →A landmark Phase III clinical trial reveals that the novel RAS(ON) inhibitor daraxonrasib doubles median overall surviva...
Read More →In a landmark medical breakthrough, researchers have successfully utilized autologous stem-cell therapy to restore endog...
Read More →University of Oxford researchers have published groundbreaking Phase II clinical trial results in Nature Medicine, demon...
Read More →Yale School of Medicine researchers have identified two proteins, mGluR4 and NPDC1, that facilitate the spread of misfol...
Read More →A large UK clinical trial published in The Lancet Infectious Diseases demonstrates that repurposed antihistamines and co...
Read More →Cancer Research UK, alongside Cytovation and the Norwegian Cancer Society, has launched a global Phase II trial for adva...
Read More →The Advanced Research Projects Agency for Health (ARPA-H) officially launched the Sprint for Women’s Health on July 13...
Read More →A National Institutes of Health-funded team has engineered a compact CRISPR enzyme, Al3Cas12f, enabling precise in-vivo ...
Read More →A study led by Flinders University reveals that tau protein, best known for its role in Alzheimer's disease, is essentia...
Read More →A landmark study reveals that high consumption of ultra-processed foods significantly alters blood metabolites, increasi...
Read More →Dwayne Johnson officially unveiled the 'Project Iron' Global Youth Athletic Foundation on July 11, 2026. The comprehensi...
Read More →